Inotec AMD Revenue and Competitors

Waterbeach,

Location

$15.9M

Total Funding

Estimated Revenue & Valuation

  • Inotec AMD's estimated annual revenue is currently $6.9M per year.(i)
  • Inotec AMD's estimated revenue per employee is $125,500
  • Inotec AMD's total funding is $15.9M.

Employee Data

  • Inotec AMD has 55 Employees.(i)
  • Inotec AMD grew their employee count by 12% last year.

Inotec AMD's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP Global MarketingReveal Email/Phone
3
VP Sales, North AmericaReveal Email/Phone
4
Chief Operations OfficerReveal Email/Phone
5
Director StrategyReveal Email/Phone
6
Global Medical Affairs DirectorReveal Email/Phone
7
Sr. Clinical ManagerReveal Email/Phone
8
Manufacturing ManagerReveal Email/Phone
9
Digital Marketing ManagerReveal Email/Phone
10
Account ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.1M49-18%$10MN/A
#2
$30.4M12129%N/AN/A
#3
$139.8M913-3%$200KN/A
#4
$84.1M0N/A$1.2MN/A
#5
$43.4M17330%N/AN/A
#6
$64.5M25712%N/AN/A
#7
$64.3M20526%$129.6MN/A
#8
$19.6M78-7%N/AN/A
#9
$65.8M2627%N/AN/A
#10
$73.7M23520%$115.5MN/A
Add Company

What Is Inotec AMD?

Inotec AMD is an exciting Cambridge based company that was formed specifically to introduce a new technology to wound care specialists and health care providers around the world. NATROX® Oxygen Wound Therapy is an innovative but simple device that delivers continuous pure humidified oxygen directly to the wound bed, thus stimulating and improving wound healing. As NATROX® is battery operated, completely portable and totally silent, this active therapy can be maintained 24 hours a day, 7 a week until the wound heals, thus making it perfectly suited to the home care setting. NATROX® Oxygen Wound Therapy has been designed simply to heal wounds.

keywords:N/A

$15.9M

Total Funding

55

Number of Employees

$6.9M

Revenue (est)

12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Inotec AMD News

2022-03-22 - Investing in private companies – an interview with Gayle Bowen

... popular investment to date, in terms of amount raised, has been a Series C private offer for oxygen wound therapy developer, Inotec AMD.

2021-03-24 - Inotec AMD secures £3.4m towards Series C funding from Wealth Club

Inotec AMD secures £3.4m towards Series C funding from Wealth Club 24-03-2021 Inotec AMD is delighted to have secured Wealth Club investment towards its Series C funding. This investment will allow the organisation to focus and drive adoption of its NATROX® Oxygen Wound Therapy within the foc ...

2021-03-24 - Inotec AMD secures £3.4m towards Series C funding from Wealth Club

Inotec AMD secures £3.4m towards Series C funding from Wealth Club 24-03-2021 Inotec AMD is delighted to have secured Wealth Club investment towards its Series C funding. This investment will allow the organisation to focus and drive adoption of its NATROX® Oxygen Wound Therapy within the foc ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$61.1M171-9%N/A
#2
$69.2M21712%N/A